DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial
Table 4
Vaccine-Induced Sero-Positivity/Sero-Reactivity (VISP/R) through Study Week 42.